Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$258,701
+$13,920 QoQ
Shares Held
516
+3.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,131
of 2,606 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aspen Grove Capital, LLC holds $984,048 across 2 Diagnostics & Research names. TMO ranks #2 (26.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
3,808 | $725,347 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
516 | $258,701 |
All Filings in TMO
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $258,701 | 516 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $244,781 | 498 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $292,042 | 504 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $239,599 | 494 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $202,730 | 500 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $251,139 | 406 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $492,723 | 891 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $479,498 | 825 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $436,309 | 822 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $500,095 | 988 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $536,359 | 1,028 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $687,609 | 1,193 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $593,643 | 1,078 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||